At-home Blood Collection Devices Market - Global Forecast to 2029
商品番号 : SMB-66787
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年9月 |
| ページ数 | 269 |
| 図表数 | 334 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The valuation of the at-home blood collection devices market in 2024 is USD 93 million and this market is projected to reach USD 135 million by 2029, growing at a CAGR of 7.6% for the period from 2024 to 2029.
2024 年の家庭用採血装置市場の評価額は 9,300 万ドルで、この市場は 2029 年までに 1 億 3,500 万ドルに達すると予測され 2024年から 2029 年までの期間は 7.6% の CAGR で成長します。
High demand for at-home blood collection & microsampling devices is primarily on account of rising infectious diseases, chronic disorders, and lifestyle-related diseases.
Pathogenic microorganisms, a continuous danger to public health, have been a major threat and reason for many deathly infectious diseases causing outbreaks all over the world. Periodic monitoring of the viral load, antibodies, and other biomarkers is necessary in infectious diseases like HIV/AIDS, hepatitis, and new viral outbreaks to trace the progression of disease and effectiveness of treatment.
At-home blood collection devices are functional because they allow patients to collect blood samples within their environment, which reduces exposure in healthcare settings and allows for timely testing. The ease of use, privacy, and convenience are what drives this trend with the at-home blood collection device. Hence, due to increased infectious diseases cases, it should boost the growth and adoption of at-home blood collection kits.
“Fingerstick method segment has taken the larger portion of the at-home blood collection devices market, by collection method, during the forecast period.”
The at-home blood collection devices market can be segmented, based on the collection method, into fingerstick, push-button, and other sample collection methods. In 2023, the fingerstick method held the major share of the at-home blood collection devices market. Moreover, broad acceptance of fingerstick has been attributed to compliance with regulatory standards that ascertains additional safety and reliability for its use at home. This further consolidates its leading position on the market, as it can easily find its place within daily routine and allow regular health monitoring without professional interventions.
“Liquid samples segment accounted for the highest growth rate in the at-home blood collection devices market, by sample type, during the forecast period.”
The at-home blood collection devices market is further divided into liquid and dried samples based on the type of sample. Liquid blood samples are expected to grow at a higher CAGR in the at-home blood collection devices market as compared to dried samples, due to their superior performance for delivering accurate and immediate diagnostic results. Compared to a dried sample that is to be rehydrated and its problems of stability and degradation, liquid blood samples are way more reliable for the same purpose. Another reason blood in its liquid form is becoming more favored is that it is easier to collect enough volume to perform a wide variety of tests, and technological advances make this process easy to conduct and relatively painless. It is foreseen that liquid blood samples will continue to see rapid market growth due to their support for advanced testing methodologies and an increasing demand for real-time health monitoring.
“Asia Pacific: The fastest-growing region in at-home blood collection devices market.”
The worldwide market for at-home blood collection devices is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is poised to experience the most notable CAGR within the at-home blood collection devices market. Increasing collaborations between academic institutions, research organizations, and healthcare companies in the Asia Pacific region contribute to the advancement and commercialization of at-home blood collection devices technologies.
Rapid urbanization and growing disposable incomes have resulted in increased investments in healthcare and growing consumer demand for convenient health monitoring solutions.
The break-up of the profile of primary participants in the at-home blood collection devices market:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C-level – 27%, D-level – 18%, and Others – 55%
- By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 4%
The key players in this market are Trajan Group Holdings Limited (Australia), Tasso, Inc. (US), YourBio Health, Inc. (US), A. Menarini Diagnostics (UK), R-Biopharm AG (Germany), Sussex Pathology Limited (UK), ImmunoServ (UK), Labonovum (Netherlands), Alpha Laboratories (UK), Lipomic Healthcare (India), Tri-Tech Forensics (US), RDA Spot Inc (Lithuania), Spot On Sciences (US), Capitainer (Sweden), PanoHealth (US), Lameditech (South Korea), Sara Healthcare (India), Owen Mumford Ltd (UK), RedDrop Dx, Inc. (US), AdvaCare Pharma (US), Naulakha Industries (India), and Phoenix Healthcare Solutions, LLC (US).
Research Coverage:
This research report categorizes the at-home blood collection devices market by product (Fingerstick Blood Collection Kits, DBS Collection Kits, Lancets, Other Products), by collection methods (Fingerstick Method, Push-button Method, Other Methods), by usability (Single-use Blood Collection Devices and Reusable Blood Collection Devices), by sample type (Dried Blood Samples and Liquid Blood Samples), by device type (Self-collection Devices and Professional Collection Devices), by application (Disease Diagnostics, Health Screening & Preventive Health, Clinical Trials & Research, Other Applications), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the at-home blood collection devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the at-home blood collection devices market. Competitive analysis of upcoming startups in the at-home blood collection devices market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall at-home blood collection devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Increasing burden of chronic disorders and lifestyle-related health conditions, Increasing prevalence of infectious diseases, Rising geriatric population and incidence of age-associated diseases, and Rising demand for painless devices and growing technological advancements), opportunities (Growth opportunities in emerging economies), restraints (Unregulated use of products for at-home blood collection and Pricing pressure owing to reimbursement cuts and budget constraints), and challenges (Inadequate access to microsampling devices in resource-limited areas) influencing the growth of the at-home blood collection devices market market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the at-home blood collection devices market market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the at-home blood collection devices market market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the at-home blood collection devices market market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Tasso, Inc. (US), Trajan Group Holdings Limited (Australia), YourBio Health, Inc. (US), Capitainer (Sweden), and A. Menarini Diagnostics s.r.l (UK).
Table of Contents
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS & EXCLUSIONS 27
1.3 STUDY SCOPE 28
1.3.1 MARKETS COVERED 28
1.3.2 YEARS CONSIDERED 29
1.3.3 CURRENCY CONSIDERED 29
1.4 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.2 RESEARCH APPROACH 30
2.2.1 SECONDARY DATA 31
2.2.1.1 Key data from secondary sources 32
2.2.2 PRIMARY DATA 33
2.2.2.1 Primary sources 33
2.2.2.2 Key data from primary sources 34
2.2.2.3 Key industry insights 35
2.2.2.4 Breakdown of primary interviews 35
2.3 MARKET SIZE ESTIMATION 36
2.3.1 BOTTOM-UP APPROACH 36
2.3.1.1 Approach 1: Company revenue estimation approach 37
2.3.1.2 Approach 2: Presentations of companies and primary interviews 37
2.3.1.3 Growth forecast 37
2.3.1.4 CAGR projections 38
2.3.2 TOP-DOWN APPROACH 38
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 39
2.5 MARKET SHARE 41
2.6 STUDY ASSUMPTIONS 41
2.7 GROWTH RATE ASSUMPTIONS 41
2.8 RISK ASSESSMENT 42
2.8.1 RISK ASSESSMENT: AT-HOME BLOOD COLLECTION DEVICES MARKET 42
2.9 LIMITATIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 50
4.1 AT-HOME BLOOD COLLECTION DEVICES MARKET OVERVIEW 50
4.2 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2024 VS. 2029 51
4.3 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2024 VS. 2029 51
4.4 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD,
2024 VS. 2029 52
4.5 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 52
4.6 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2024 VS. 2029 53
4.7 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 53
4.8 AT-HOME BLOOD COLLECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
5.2.1 DRIVERS 56
5.2.1.1 Increasing burden of chronic disorders and lifestyle-related health conditions 56
5.2.1.2 Increasing prevalence of infectious diseases 57
5.2.1.3 Rising geriatric population and incidence of age-associated diseases 58
5.2.1.4 Rising demand for painless devices and growing technological advancements 59
5.2.2 RESTRAINTS 60
5.2.2.1 Unregulated use of products for at-home blood collection 60
5.2.2.2 Pricing pressure owing to reimbursement cuts and budget constraints 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growth opportunities in emerging economies 61
5.2.4 CHALLENGES 61
5.2.4.1 Inadequate access to microsampling devices in resource-limited areas 61
5.3 PRICING ANALYSIS 62
5.4 PATENT ANALYSIS 64
5.4.1 LIST OF MAJOR PATENTS 65
5.5 VALUE CHAIN ANALYSIS 66
5.6 SUPPLY CHAIN ANALYSIS 67
5.7 TRADE ANALYSIS 68
5.7.1 TRADE ANALYSIS FOR LANCETS, CANNULAS, AND CATHETERS 68
5.8 ECOSYSTEM ANALYSIS 69
5.8.1 AT-HOME BLOOD COLLECTION DEVICES MARKET: ROLE IN ECOSYSTEM 70
5.9 PORTER’S FIVE FORCES ANALYSIS 71
5.9.1 THREAT OF NEW ENTRANTS 72
5.9.2 THREAT OF SUBSTITUTES 72
5.9.3 BARGAINING POWER OF BUYERS 72
5.9.4 BARGAINING POWER OF SUPPLIERS 72
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 73
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 73
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 73
5.10.2 BUYING CRITERIA 74
5.11 REGULATORY LANDSCAPE 74
5.11.1 NORTH AMERICA 75
5.11.1.1 US 75
5.11.1.2 Canada 75
5.11.2 EUROPE 75
5.11.3 ASIA PACIFIC 76
5.11.3.1 China 76
5.11.3.2 Japan 76
5.11.3.3 India 77
5.11.4 LATIN AMERICA 77
5.11.4.1 Brazil 77
5.11.4.2 Mexico 78
5.11.5 MIDDLE EAST 78
5.11.5.1 Africa 78
5.11.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
5.12 TECHNOLOGY ANALYSIS 80
5.12.1 KEY TECHNOLOGIES 81
5.12.1.1 Lancets 81
5.12.2 COMPLEMENTARY TECHNOLOGIES 81
5.12.2.1 Dried Blood Spot Collection 81
5.12.3 ADJACENT TECHNOLOGIES 82
5.12.3.1 Laser Lancets 82
5.13 KEY CONFERENCES AND EVENTS IN 2024–2025 82
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83
5.15 INVESTMENT & FUNDING SCENARIO 84
5.16 CASE STUDY ANALYSIS 84
5.16.1 ASSESSING DIAGNOSTIC ACCURACY OF VOLUMETRIC ABSORPTIVE MICROSAMPLING COMPARED TO GOLD STANDARD METHOD 84
5.17 IMPACT OF AI ON AT-HOME BLOOD COLLECTION DEVICES MARKET 85
6 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT 86
6.1 INTRODUCTION 87
6.2 LANCETS 87
6.2.1 HIGH AFFORDABILITY AND FREQUENT USE TO DRIVE UPTAKE OF LANCETS 87
6.3 DRIED BLOOD SPOT COLLECTION KITS 90
6.3.1 SUPPORT FOR SHORT-TERM STORAGE TO DRIVE MARKET 90
6.4 FINGERSTICK BLOOD COLLECTION KITS 93
6.4.1 DEMAND FOR PAINLESS TECHNOLOGIES TO HAMPER MARKET GROWTH 93
6.5 OTHER PRODUCTS 96
7 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE 100
7.1 INTRODUCTION 101
7.1.1 PRIMARY NOTES 101
7.2 LIQUID BLOOD SAMPLES 102
7.2.1 FAVORABLE REGULATORY AND INVESTMENT LANDSCAPES TO DRIVE ADOPTION 102
7.3 DRIED BLOOD SAMPLES 105
7.3.1 EASY COLLECTION AND REDUCED REQUIREMENT FOR COLD STORAGE TO SUPPORT UPTAKE OF DRIED BLOOD-BASED DEVICES 105
8 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD 110
8.1 INTRODUCTION 111
8.2 FINGERSTICK SAMPLE COLLECTION 111
8.2.1 HIGH AFFORDABILITY AND ACCESSIBILITY TO DRIVE MARKET 111
8.3 PUSH-BUTTON SAMPLE COLLECTION 114
8.3.1 CONSISTENCY AND RELIABILITY TO SUPPORT HOME-USE ADOPTION 114
8.4 OTHER SAMPLE COLLECTION METHODS 117
9 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE 121
9.1 INTRODUCTION 122
9.2 SELF-COLLECTION DEVICES 122
9.2.1 INCREASED PRIVACY AND CONFIDENTIALITY OF SELF-COLLECTION DEVICES TO DRIVE MARKET 122
9.3 PROFESSIONAL COLLECTION DEVICES 125
9.3.1 GROWING AWARENESS AND USAGE OF SELF-COLLECTION DEVICES TO HINDER ADOPTION 125
10 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY 129
10.1 INTRODUCTION 130
10.2 SINGLE-USE BLOOD COLLECTION DEVICES 130
10.2.1 INCREASED AFFORDABILITY OF SINGLE-USE DEVICES TO DRIVE ADOPTION 130
10.3 REUSABLE BLOOD COLLECTION DEVICES 133
10.3.1 NEED FOR PAINLESS TECHNOLOGIES TO PROPEL UPTAKE 133
11 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION 137
11.1 INTRODUCTION 138
11.2 HEALTH SCREENING & PREVENTIVE HEALTH 138
11.2.1 GROWING AWARENESS ON REGULAR HEALTH ASSESSMENTS TO FUEL MARKET GROWTH 138
11.3 DISEASE DIAGNOSTICS 141
11.3.1 INCREASING DEMAND FOR EARLY DISEASE DETECTION TO DRIVE MARKET 141
11.4 CLINICAL TRIALS & RESEARCH 144
11.4.1 NEED FOR COMPREHENSIVE & STANDARDIZED RESEARCH FINDINGS TO PROPEL MARKET GROWTH 144
11.5 OTHER APPLICATIONS 147
12 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY REGION 151
12.1 INTRODUCTION 152
12.2 NORTH AMERICA 152
12.2.1 US 156
12.2.1.1 Advanced infrastructure and high healthcare expenditure to drive market 156
12.2.2 CANADA 159
12.2.2.1 Rising prevalence of kidney diseases to propel demand 159
12.3 EUROPE 162
12.3.1 GERMANY 165
12.3.1.1 Increasing healthcare expenditure to propel market 165
12.3.2 UK 168
12.3.2.1 Increasing prevalence of lifestyle diseases to drive market 168
12.3.3 FRANCE 171
12.3.3.1 Rising R&D expenditure to provide growth opportunities 171
12.3.4 ITALY 173
12.3.4.1 Growing diabetes prevalence to sustain demand for testing 173
12.3.5 SPAIN 176
12.3.5.1 Growth in elderly demographics in Spain to propel market 176
12.3.6 REST OF EUROPE 179
12.4 ASIA PACIFIC 181
12.4.1 CHINA 185
12.4.1.1 China to hold largest share of APAC market 185
12.4.2 JAPAN 188
12.4.2.1 Well-established healthcare system to support market 188
12.4.3 INDIA 191
12.4.3.1 Large patient population and rising prevalence of chronic diseases to drive market 191
12.4.4 REST OF ASIA PACIFIC 194
12.5 LATIN AMERICA 197
12.5.1 BRAZIL 200
12.5.1.1 Brazil to dominate LATAM market 200
12.5.2 MEXICO 203
12.5.2.1 Rising prevalence of chronic diseases to drive market 203
12.5.3 REST OF LATIN AMERICA 206
12.6 MIDDLE EAST & AFRICA 208
12.6.1 INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET 208
12.7 GCC COUNTRIES 211
12.7.1 INFRASTRUCTURAL DEVELOPMENT AND GROWING DISEASE INCIDENCE TO DRIVE MARKET 211
13 COMPETITIVE LANDSCAPE 215
13.1 INTRODUCTION 215
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 215
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN AT-HOME BLOOD COLLECTION DEVICES MARKET 215
13.3 REVENUE SHARE ANALYSIS 217
13.4 MARKET SHARE ANALYSIS 217
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 219
13.5.1 STARS 219
13.5.2 EMERGING LEADERS 219
13.5.3 PERVASIVE PLAYERS 219
13.5.4 PARTICIPANTS 219
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 221
13.5.5.1 Company footprint 221
13.5.5.2 Product footprint 222
13.5.5.3 Regional footprint 223
13.5.5.4 Application footprint 224
13.5.5.5 Sample type footprint 225
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 225
13.6.1 PROGRESSIVE COMPANIES 225
13.6.2 RESPONSIVE COMPANIES 225
13.6.3 DYNAMIC COMPANIES 226
13.6.4 STARTING BLOCKS 226
13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, 2023 227
13.7 VALUATION & FINANCIAL METRICS 227
13.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 228
13.8.1 SARA HEALTHCARE 229
13.8.2 OWEN MUMFORD 229
13.8.3 A. MENARINI DIAGNOSTICS S.R.L 229
13.9 COMPETITIVE SCENARIO 229
13.9.1 PRODUCT LAUNCHES 229
13.9.2 DEALS 230
13.9.3 EXPANSIONS 231
13.9.4 OTHER DEVELOPMENTS 232
14 COMPANY PROFILES 233
14.1 KEY PLAYERS 233
14.1.1 TASSO, INC. 233
14.1.1.1 Business overview 233
14.1.1.2 Products offered 233
14.1.1.3 Recent developments 234
14.1.1.3.1 Product approvals 234
14.1.1.3.2 Deals 234
14.1.1.4 MnM view 236
14.1.1.4.1 Right to win 236
14.1.1.4.2 Strategic choices 236
14.1.1.4.3 Weaknesses & competitive threats 236
14.1.2 TRAJAN GROUP HOLDINGS LIMITED 237
14.1.2.1 Business overview 237
14.1.2.2 Products offered 238
14.1.2.3 Recent developments 239
14.1.2.3.1 Deals 239
14.1.2.3.2 Other developments 240
14.1.2.4 MnM view 240
14.1.2.4.1 Right to win 240
14.1.2.4.2 Strategic choices 240
14.1.2.4.3 Weaknesses & competitive threats 240
14.1.3 YOURBIO HEALTH, INC. 241
14.1.3.1 Business overview 241
14.1.3.2 Products offered 241
14.1.3.3 Recent developments 242
14.1.3.3.1 Product approvals 242
14.1.3.4 MnM view 242
14.1.3.4.1 Right to win 242
14.1.3.4.2 Strategic choices 242
14.1.3.4.3 Weaknesses & competitive threats 242
14.1.4 CAPITAINER 243
14.1.4.1 Business overview 243
14.1.4.2 Products offered 243
14.1.4.3 Recent developments 244
14.1.4.3.1 Product launches 244
14.1.4.3.2 Deals 244
14.1.4.3.3 Other developments 245
14.1.5 A. MENARINI DIAGNOSTICS S.R.L (MENARINI GROUP) 246
14.1.5.1 Business overview 246
14.1.6 R-BIOPHARM AG 247
14.1.6.1 Business overview 247
14.1.6.2 Products offered 247
14.1.7 SUSSEX PATHOLOGY LIMITED 248
14.1.7.1 Business overview 248
14.1.7.2 Products offered 248
14.1.7.3 Recent developments 248
14.1.7.3.1 Deals 248
14.1.8 IMMUNOSERV 249
14.1.8.1 Business overview 249
14.1.8.2 Products offered 249
14.1.9 LABONOVUM 250
14.1.9.1 Business overview 250
14.1.9.2 Products offered 250
14.1.10 ALPHA LABORATORIES 251
14.1.10.1 Business overview 251
14.1.10.2 Products offered 251
14.1.11 LIPOMIC HEALTHCARE 252
14.1.11.1 Business overview 252
14.1.11.2 Products offered 252
14.1.12 TRI-TECH FORENSICS 253
14.1.12.1 Business overview 253
14.1.12.2 Products offered 253
14.2 OTHER PLAYERS 254
14.2.1 RDA SPOT INC. 254
14.2.2 SPOT ON SCIENCES 254
14.2.3 PANOHEALTH 255
14.2.4 LAMEDITECH 255
14.2.5 SARA HEALTHCARE 256
14.2.6 OWEN MUMFORD LTD 256
14.2.7 REDDROP DX, INC. 257
14.2.8 ADVACARE PHARMA 257
14.2.9 NAULAKHA INDUSTRIES 258
14.2.10 PHOENIX HEALTHCARE SOLUTIONS, LLC 259
15 APPENDIX 260
15.1 DISCUSSION GUIDE 260
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 265
15.3 CUSTOMIZATION OPTIONS 267
15.4 RELATED REPORTS 267
15.5 AUTHOR DETAILS 268
LIST OF TABLES
TABLE 1 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER,
BY REGION (2022 VS 2030 VS 2050) 59
TABLE 2 INDICATIVE PRICING OF KEY PLAYERS, BY PRODUCT 62
TABLE 4 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019–2023 (USD MILLION) 68
TABLE 5 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019–2023 (USD MILLION) 69
TABLE 6 AT-HOME BLOOD COLLECTION DEVICES MARKET: PORTER’S
FIVE FORCES ANALYSIS 72
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
AT-HOME BLOOD COLLECTION DEVICES (%) 73
TABLE 8 KEY BUYING CRITERIA FOR AT-HOME BLOOD COLLECTION DEVICES 74
TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 75
TABLE 10 EUROPE: CLASSIFICATION OF DEVICES 76
TABLE 11 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 77
TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 79
TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 79
TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 79
TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
TABLE 16 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 17 AT-HOME BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2024–2025 82
TABLE 18 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 87
TABLE 19 COMMERCIALLY AVAILABLE LANCETS, BY COMPANY 88
TABLE 20 LANCETS MARKET, BY REGION, 2022–2029 (USD MILLION) 88
TABLE 21 NORTH AMERICA: LANCETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 89
TABLE 22 EUROPE: LANCETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 89
TABLE 23 ASIA PACIFIC: LANCETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 89
TABLE 24 LATIN AMERICA: LANCETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 90
TABLE 25 COMMERCIALLY AVAILABLE DBS COLLECTION KITS, BY COMPANY 90
TABLE 26 DBS COLLECTION KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 91
TABLE 27 NORTH AMERICA: DBS COLLECTION KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 91
TABLE 28 EUROPE: DBS COLLECTION KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 92
TABLE 29 ASIA PACIFIC: DBS COLLECTION KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 92
TABLE 30 LATIN AMERICA: DBS COLLECTION KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 93
TABLE 31 FINGERSTICK BLOOD COLLECTION KITS MARKET, BY REGION,
2022–2029 (USD MILLION) 94
TABLE 32 NORTH AMERICA: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 94
TABLE 33 EUROPE: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 95
TABLE 34 ASIA PACIFIC: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 95
TABLE 35 LATIN AMERICA: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 96
TABLE 36 OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, BY REGION,
2022–2029 (USD MILLION) 97
TABLE 37 NORTH AMERICA: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 38 EUROPE: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 98
TABLE 39 ASIA PACIFIC: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET,
2022–2029 (USD MILLION) 98
TABLE 40 LATIN AMERICA: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, 2022–2029 (USD MILLION) 99
TABLE 41 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE,
2022–2029 (USD MILLION) 101
TABLE 42 LIQUID BLOOD SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS,
BY COMPANY 103
TABLE 43 AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 103
TABLE 44 NORTH AMERICA: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 45 EUROPE: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 46 ASIA PACIFIC: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 105
TABLE 47 LATIN AMERICA: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 105
TABLE 48 DRIED BLOOD SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS,
BY COMPANY 106
TABLE 49 COMPARATIVE ANALYSIS: DRIED BLOOD SPOT VS. CONVENTIONAL SAMPLES (WHOLE BLOOD, SERUM, AND PLASMA) 107
TABLE 50 AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 107
TABLE 51 NORTH AMERICA: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 52 EUROPE: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 53 ASIA PACIFIC: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 54 LATIN AMERICA: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 55 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 111
TABLE 56 FINGERSTICK SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS,
BY COMPANY 112
TABLE 57 AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 112
TABLE 58 NORTH AMERICA: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 59 EUROPE: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 60 ASIA PACIFIC: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 61 LATIN AMERICA: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 62 PUSH-BUTTON SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS,
BY COMPANY 115
TABLE 63 AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 115
TABLE 64 NORTH AMERICA: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 65 EUROPE: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 66 ASIA PACIFIC: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 67 LATIN AMERICA: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 68 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY REGION, 2022–2029 (USD MILLION) 118
TABLE 69 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 70 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 71 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 72 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 73 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 122
TABLE 74 AT-HOME SELF-COLLECTION DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 123
TABLE 75 NORTH AMERICA: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 76 EUROPE: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 124
TABLE 77 ASIA PACIFIC: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 125
TABLE 78 LATIN AMERICA: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 79 AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 126
TABLE 80 NORTH AMERICA: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 81 EUROPE: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 82 ASIA PACIFIC: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 83 LATIN AMERICA: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 84 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 130
TABLE 85 SINGLE-USE DEVICES: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY 131
TABLE 86 SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 131
TABLE 87 NORTH AMERICA: SINGLE-USE BLOOD COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 88 EUROPE: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 89 ASIA PACIFIC: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 90 LATIN AMERICA: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 91 REUSABLE BLOOD COLLECTION DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 134
TABLE 92 NORTH AMERICA: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 93 EUROPE: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 135
TABLE 94 ASIA PACIFIC: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 95 LATIN AMERICA: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 96 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 138
TABLE 97 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY REGION, 2022–2029 (USD MILLION) 139
TABLE 98 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 99 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 100 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 101 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 102 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS,
BY REGION, 2022–2029 (USD MILLION) 142
TABLE 103 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 104 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 105 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 106 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 107 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY REGION, 2022–2029 (USD MILLION) 145
TABLE 108 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 109 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 110 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 111 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 112 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 148
TABLE 113 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 114 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 115 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 116 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 117 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 152
TABLE 118 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 119 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 154
TABLE 120 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY SAMPLE TYPE, 2022–2029 (USD MILLION) 154
TABLE 121 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY COLLECTION METHOD, 2022–2029 (USD MILLION) 155
TABLE 122 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 155
TABLE 123 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION) 155
TABLE 124 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 156
TABLE 125 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 157
TABLE 126 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE,
2022–2029 (USD MILLION) 158
TABLE 127 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 158
TABLE 128 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 158
TABLE 129 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 159
TABLE 130 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 159
TABLE 131 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 160
TABLE 132 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 160
TABLE 133 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 161
TABLE 134 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 161
TABLE 135 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 161
TABLE 136 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 162
TABLE 137 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 163
TABLE 138 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 163
TABLE 139 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 164
TABLE 140 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 164
TABLE 141 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 164
TABLE 142 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 165
TABLE 143 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 165
TABLE 144 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 166
TABLE 145 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 166
TABLE 146 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 167
TABLE 147 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 167
TABLE 148 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 167
TABLE 149 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 168
TABLE 150 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 169
TABLE 151 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE,
2022–2029 (USD MILLION) 169
TABLE 152 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 169
TABLE 153 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 170
TABLE 154 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 170
TABLE 155 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 170
TABLE 156 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 171
TABLE 157 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 172
TABLE 158 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 172
TABLE 159 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 172
TABLE 160 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 173
TABLE 161 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 173
TABLE 162 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 174
TABLE 163 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE,
2022–2029 (USD MILLION) 174
TABLE 164 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 175
TABLE 165 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 175
TABLE 166 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 175
TABLE 167 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 176
TABLE 168 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 177
TABLE 169 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE,
2022–2029 (USD MILLION) 177
TABLE 170 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 177
TABLE 171 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 178
TABLE 172 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 178
TABLE 173 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 178
TABLE 174 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 179
TABLE 175 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 180
TABLE 176 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY COLLECTION METHOD, 2022–2029 (USD MILLION) 180
TABLE 177 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 180
TABLE 178 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION) 181
TABLE 179 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 181
TABLE 180 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 181 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 183
TABLE 182 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 183
TABLE 183 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 184
TABLE 184 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 184
TABLE 185 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION) 184
TABLE 186 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 185
TABLE 187 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 186
TABLE 188 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE,
2022–2029 (USD MILLION) 186
TABLE 189 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 187
TABLE 190 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 187
TABLE 191 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 187
TABLE 192 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 188
TABLE 193 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 189
TABLE 194 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE,
2022–2029 (USD MILLION) 189
TABLE 195 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 190
TABLE 196 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 190
TABLE 197 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 190
TABLE 198 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 191
TABLE 199 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 192
TABLE 200 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE,
2022–2029 (USD MILLION) 193
TABLE 201 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 193
TABLE 202 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 193
TABLE 203 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 194
TABLE 204 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 194
TABLE 205 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 195
TABLE 206 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY SAMPLE TYPE, 2022–2029 (USD MILLION) 195
TABLE 207 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY COLLECTION METHOD, 2022–2029 (USD MILLION) 196
TABLE 208 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 196
TABLE 209 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY USABILITY, 2022–2029 (USD MILLION) 196
TABLE 210 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 197
TABLE 211 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 212 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 198
TABLE 213 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 199
TABLE 214 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 199
TABLE 215 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 199
TABLE 216 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION) 200
TABLE 217 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 200
TABLE 218 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 201
TABLE 219 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 201
TABLE 220 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 202
TABLE 221 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 202
TABLE 222 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 202
TABLE 223 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 203
TABLE 224 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 204
TABLE 225 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 204
TABLE 226 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION) 204
TABLE 227 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 205
TABLE 228 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2022–2029 (USD MILLION) 205
TABLE 229 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 205
TABLE 230 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 206
TABLE 231 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY SAMPLE TYPE, 2022–2029 (USD MILLION) 207
TABLE 232 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY COLLECTION METHOD, 2022–2029 (USD MILLION) 207
TABLE 233 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 207
TABLE 234 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY USABILITY, 2022–2029 (USD MILLION) 208
TABLE 235 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 208
TABLE 236 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 209
TABLE 237 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY SAMPLE TYPE, 2022–2029 (USD MILLION) 210
TABLE 238 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY COLLECTION METHOD, 2022–2029 (USD MILLION) 210
TABLE 239 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 210
TABLE 240 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY USABILITY, 2022–2029 (USD MILLION) 211
TABLE 241 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 211
TABLE 242 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 212
TABLE 243 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION) 213
TABLE 244 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY COLLECTION METHOD, 2022–2029 (USD MILLION) 213
TABLE 245 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 213
TABLE 246 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION) 214
TABLE 247 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 214
TABLE 248 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 215
TABLE 249 AT-HOME BLOOD COLLECTION DEVICES MARKET: DEGREE OF COMPETITION 218
TABLE 250 AT-HOME BLOOD COLLECTION DEVICES MARKET: PRODUCT FOOTPRINT 222
TABLE 251 AT-HOME BLOOD COLLECTION DEVICES MARKET: REGIONAL FOOTPRINT 223
TABLE 252 AT-HOME BLOOD COLLECTION DEVICES MARKET: APPLICATION FOOTPRINT 224
TABLE 253 AT-HOME BLOOD COLLECTION DEVICES MARKET: SAMPLE TYPE FOOTPRINT 225
TABLE 254 AT-HOME BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 227
TABLE 255 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS 227
TABLE 256 AT-HOME BLOOD COLLECTION DEVICES MARKET: PRODUCT LAUNCHES,
JANUARY 2021–JUNE 2024 229
TABLE 257 AT-HOME BLOOD COLLECTION DEVICES MARKET: DEALS,
JANUARY 2021– JUNE 2024 230
TABLE 258 AT-HOME BLOOD COLLECTION DEVICES MARKET: EXPANSIONS,
JANUARY 2021– JUNE 2024 231
TABLE 259 AT-HOME BLOOD COLLECTION DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021– JUNE 2024 232
TABLE 260 TASSO, INC.: COMPANY OVERVIEW 233
TABLE 261 TASSO, INC.: PRODUCTS OFFERED 233
TABLE 262 TASSO, INC.: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024 234
TABLE 263 TASSO, INC.: DEALS, JANUARY 2021–JUNE 2024 234
TABLE 264 TRAJAN GROUP HOLDINGS LIMITED: COMPANY OVERVIEW 237
TABLE 265 TRAJAN GROUP HOLDINGS LIMITED: PRODUCTS OFFERED 238
TABLE 266 TRAJAN GROUP HOLDINGS LIMITED: DEALS, JANUARY 2021–JUNE 2024 239
TABLE 267 TRAJAN GROUP HOLDINGS LIMITED: OTHER DEVELOPMENTS,
JANUARY 2021–JUNE 2024 240
TABLE 268 YOURBIO HEALTH, INC.: COMPANY OVERVIEW 241
TABLE 269 YOURBIO HEALTH, INC.: PRODUCTS OFFERED 241
TABLE 270 YOURBIO HEALTH, INC.: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024 242
TABLE 271 CAPITAINER: COMPANY OVERVIEW 243
TABLE 272 CAPITAINER: PRODUCTS OFFERED 243
TABLE 273 CAPITAINER: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 244
TABLE 274 CAPITAINER: DEALS, JANUARY 2021–JUNE 2024 244
TABLE 275 CAPITAINER: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024 245
TABLE 276 A. MENARINI DIAGNOSTICS S.R.L.: COMPANY OVERVIEW 246
TABLE 277 A. MENARINI DIAGNOSTICS S.R.L.: PRODUCTS OFFERED 246
TABLE 278 R-BIOPHARM AG: COMPANY OVERVIEW 247
TABLE 279 R-BIOPHARM AG: PRODUCTS OFFERED 247
TABLE 280 SUSSEX PATHOLOGY LIMITED: COMPANY OVERVIEW 248
TABLE 281 SUSSEX PATHOLOGY LIMITED: PRODUCTS OFFERED 248
TABLE 282 SUSSEX PATHOLOGY LIMITED: DEALS, JANUARY 2021–JUNE 2024 248
TABLE 283 IMMUNOSERV: COMPANY OVERVIEW 249
TABLE 284 IMMUNOSERV: PRODUCTS OFFERED 249
TABLE 285 LABONOVUM: COMPANY OVERVIEW 250
TABLE 286 LABONOVUM: PRODUCTS OFFERED 250
TABLE 287 ALPHA LABORATORIES: COMPANY OVERVIEW 251
TABLE 288 ALPHA LABORATORIES: PRODUCTS OFFERED 251
TABLE 289 LIPOMIC HEALTHCARE: COMPANY OVERVIEW 252
TABLE 290 LIPOMIC HEALTHCARE: PRODUCTS OFFERED 252
TABLE 291 TRI-TECH FORENSICS: COMPANY OVERVIEW 253
TABLE 292 TRI-TECH FORENSICS: PRODUCTS OFFERED 253
LIST OF FIGURES
FIGURE 1 AT-HOME BLOOD COLLECTION DEVICES MARKET: RESEARCH DESIGN METHODOLOGY 30
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 36
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 37
FIGURE 5 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 38
FIGURE 6 AT-HOME BLOOD COLLECTION DEVICES MARKET: TOP-DOWN APPROACH 39
FIGURE 7 DATA TRIANGULATION METHODOLOGY 40
FIGURE 8 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2024 VS. 2029 (USD MILLION) 43
FIGURE 9 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE,
2024 VS. 2029 (USD MILLION) 44
FIGURE 10 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD,
2024 VS. 2029 (USD MILLION) 45
FIGURE 11 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE,
2024 VS. 2029 (USD MILLION) 46
FIGURE 12 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY,
2024 VS. 2029 (USD MILLION) 47
FIGURE 13 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION) 48
FIGURE 14 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY REGION,
2024 VS. 2029 (USD MILLION) 49
FIGURE 15 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND LIFESTYLE-RELATED DISORDERS TO SUPPORT MARKET GROWTH 50
FIGURE 16 LANCETS TO DOMINATE MARKET TILL 2029 51
FIGURE 17 LIQUID BLOOD SAMPLES TO HOLD LARGEST MARKET SHARE 51
FIGURE 18 FINGERSTICK AND PUSH-BUTTON METHODS TO HOLD LARGER SHARES 52
FIGURE 19 SELF-COLLECTION DEVICES TO DOMINATE MARKET IN 2029 52
FIGURE 20 SINGE-USE BLOOD COLLECTION DEVICES SEGMENT TO HOLD LARGER SHARE 53
FIGURE 21 HEALTH SCREENING & PREVENTIVE HEALTH TO ACCOUNT FOR LARGER MARKET SHARE TILL 2029 53
FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 54
FIGURE 23 AT-HOME BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
FIGURE 24 INCIDENCE OF DIABETES, 2021 VS 2045 (MILLION INDIVIDUALS) 56
FIGURE 25 AVERAGE SELLING PRICE OF LASER LANCETS, 2024 63
FIGURE 26 PATENT ANALYSIS FOR MICROSAMPLING DEVICES
(JANUARY 2014–DECEMBER 2023) 64
FIGURE 27 VALUE CHAIN ANALYSIS OF AT-HOME BLOOD COLLECTION DEVICES MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 66
FIGURE 28 AT-HOME BLOOD COLLECTION DEVICES MARKET: SUPPLY CHAIN ANALYSIS 68
FIGURE 29 AT-HOME BLOOD COLLECTION DEVICES MARKET: ECOSYSTEM ANALYSIS 69
FIGURE 30 AT-HOME BLOOD COLLECTION DEVICES MARKET:
PORTER’S FIVE FORCES ANALYSIS 71
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
AT-HOME BLOOD COLLECTION DEVICES 73
FIGURE 32 KEY BUYING CRITERIA FOR AT-HOME BLOOD COLLECTION DEVICES 74
FIGURE 33 REVENUE SHIFT IN AT-HOME BLOOD COLLECTION DEVICES MARKET 83
FIGURE 34 AT-HOME BLOOD COLLECTION DEVICES MARKET:
INVESTMENT & FUNDING SCENARIO 84
FIGURE 35 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET SNAPSHOT 153
FIGURE 36 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET SNAPSHOT 182
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AT-HOME BLOOD COLLECTION DEVICES MARKET (2023) 217
FIGURE 38 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 220
FIGURE 39 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPANY FOOTPRINT 221
FIGURE 40 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 226
FIGURE 41 AT-HOME BLOOD COLLECTION DEVICES MARKET: BRAND COMPARISON FOR LANCETS 228
FIGURE 42 TRAJAN GROUP HOLDINGS LIMITED: COMPANY SNAPSHOT (2023) 238
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 栄養補助食品用包装市場 – 2030年までの世界予測 2025-04-07
- 産業用ボイラー市場 – 2030年までの世界予測 2025-04-04
- オープンギア用潤滑油市場 – 2030年までの世界予測 2025-04-04
- 建設重機市場 – 2030年までの世界予測 2025-04-03
- 従来の創傷ケア市場 – 2030年までの世界予測 2025-04-02